Figures & data
Figure 1. (A) Incidence rate of COVID-19 breakthrough infections in vaccinated individuals with the PfizerBioNTech and Moderna vaccines. The incidence rate of breakthrough infections with the PfizerBioNTech vaccine is about twice what the rate is for the Moderna vaccine. (B) Absolute risk increase in COVID-19 breakthrough infections in vaccinated individuals with the PfizerBioNTech and Moderna vaccines. Over one year, for every 100 people treated with PfizerBioNTech and Moderna vaccines, one additional breakthrough infections would be expected with the PfizerBioNTech vaccine than with the Moderna vaccine.
![Figure 1. (A) Incidence rate of COVID-19 breakthrough infections in vaccinated individuals with the PfizerBioNTech and Moderna vaccines. The incidence rate of breakthrough infections with the PfizerBioNTech vaccine is about twice what the rate is for the Moderna vaccine. (B) Absolute risk increase in COVID-19 breakthrough infections in vaccinated individuals with the PfizerBioNTech and Moderna vaccines. Over one year, for every 100 people treated with PfizerBioNTech and Moderna vaccines, one additional breakthrough infections would be expected with the PfizerBioNTech vaccine than with the Moderna vaccine.](/cms/asset/5816133f-da39-4b15-adb2-6984fc5d7d91/ijdt_a_1995982_f0001_c.jpg)